0001411690-14-000002.txt : 20140627 0001411690-14-000002.hdr.sgml : 20140627 20140627142347 ACCESSION NUMBER: 0001411690-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140627 DATE AS OF CHANGE: 20140627 EFFECTIVENESS DATE: 20140627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioNano Genomics, Inc CENTRAL INDEX KEY: 0001411690 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-219978 FILM NUMBER: 14945484 BUSINESS ADDRESS: STREET 1: 9640 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 888-7600 MAIL ADDRESS: STREET 1: 9640 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BioNanomatrix Inc DATE OF NAME CHANGE: 20070906 D 1 primary_doc.xml X0707 D LIVE 0001411690 BioNano Genomics, Inc 9640 TOWNE CENTRE DRIVE SAN DIEGO CA CALIFORNIA 92121 (858) 888-7600 DELAWARE BioNanomatrix Inc Corporation true R. Erik Holmlin c/o BioNano Genomics, Inc. 9640 Towne Centre Drive, Suite 100 San Diego CA CALIFORNIA 92121 Executive Officer David L. Barker c/o BioNano Genomics, Inc. 9640 Towne Centre Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Brian Halak c/o BioNano Genomics, Inc. 9640 Towne Centre Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Albert A. Luderer c/o Bionano Genomics, Inc. 9640 Towne Centre Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Tracy Warren c/o BioNano Genomics, Inc. 9640 Towne Centre Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Han Cao c/o BioNano Genomics, Inc. 9640 Towne Centre Drive, Suite 100 San Diego CA CALIFORNIA 92121 Executive Officer Joel R. Jung c/o BioNano Genomics, Inc. 9640 Towne Centre Drive, Suite 100 San Diego CA CALIFORNIA 92121 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2014-06-12 false true true true false 0 6139997 5000500 1139497 Total offering amount listed above includes an aggregate of $1,039,997 receivable upon the exercise of warrants to purchase shares of the Company's Series B-1 Preferred Stock. Such warrants have not yet been exercised. false 5 0 0 0 false BioNano Genomics, Inc /s/ Joel Jung Joel Jung Chief Financial Officer 2014-06-25